| 0 |
PINEALOBLASTOMA |
76 |
0.8172 |
| 1 |
GENOTYPE DRUG RESISTANCE TEST |
39 |
0.7959 |
| 2 |
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA |
102 |
0.7907 |
| 3 |
CSF HIV ESCAPE SYNDROME |
83 |
0.6014 |
| 4 |
HIV VIRAEMIA |
122 |
0.5810 |
| 5 |
ULTRASOUND ANTENATAL SCREEN |
54 |
0.5625 |
| 6 |
VIRAL MUTATION IDENTIFIED |
1889 |
0.5123 |
| 7 |
IMMUNE RECONSTITUTION SYNDROME |
652 |
0.5050 |
| 8 |
HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION |
122 |
0.4388 |
| 9 |
HIV-ASSOCIATED NEUROCOGNITIVE DISORDER |
46 |
0.4144 |
| 10 |
VIROLOGIC FAILURE |
2168 |
0.4027 |
| 11 |
TOTAL LUNG CAPACITY INCREASED |
103 |
0.3787 |
| 12 |
BLOOD HIV RNA INCREASED |
595 |
0.3278 |
| 13 |
HEPATITIS B DNA INCREASED |
207 |
0.3071 |
| 14 |
LIPODYSTROPHY ACQUIRED |
652 |
0.3068 |
| 15 |
MITOCHONDRIAL TOXICITY |
251 |
0.3057 |
| 16 |
DANDY-WALKER SYNDROME |
70 |
0.2703 |
| 17 |
BIRTH MARK |
56 |
0.2692 |
| 18 |
BONE DEMINERALISATION |
248 |
0.2342 |
| 19 |
PATHOGEN RESISTANCE |
2035 |
0.2230 |
| 20 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS |
74 |
0.2209 |
| 21 |
MITOCHONDRIAL CYTOPATHY |
96 |
0.2182 |
| 22 |
KAPOSI'S SARCOMA |
103 |
0.2052 |
| 23 |
ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME |
105 |
0.2008 |
| 24 |
FANCONI SYNDROME ACQUIRED |
329 |
0.1873 |
| 25 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
849 |
0.1702 |
| 26 |
HEPATITIS B REACTIVATION |
532 |
0.1675 |
| 27 |
CD4 LYMPHOCYTES INCREASED |
39 |
0.1674 |
| 28 |
CONGENITAL UMBILICAL HERNIA |
61 |
0.1635 |
| 29 |
HEPATITIS B SURFACE ANTIGEN POSITIVE |
42 |
0.1533 |
| 30 |
MACROCEPHALY |
58 |
0.1495 |
| 31 |
MITOCHONDRIAL MYOPATHY |
32 |
0.1468 |
| 32 |
HEPATITIS B |
865 |
0.1434 |
| 33 |
CHORIOAMNIONITIS |
27 |
0.1421 |
| 34 |
LIPOATROPHY |
135 |
0.1418 |
| 35 |
MENINGOMYELOCELE |
84 |
0.1400 |
| 36 |
NEUTROPENIA NEONATAL |
31 |
0.1384 |
| 37 |
FACIAL WASTING |
37 |
0.1375 |
| 38 |
GENOTYPE DRUG RESISTANCE TEST POSITIVE |
136 |
0.1323 |
| 39 |
OSTEOMALACIA |
198 |
0.1281 |
| 40 |
VIRAL LOAD INCREASED |
490 |
0.1261 |
| 41 |
TRISOMY 18 |
47 |
0.1234 |
| 42 |
POLYDACTYLY |
141 |
0.1216 |
| 43 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
63 |
0.1214 |
| 44 |
FANCONI SYNDROME |
170 |
0.1201 |
| 45 |
CD4 LYMPHOCYTES DECREASED |
252 |
0.1176 |
| 46 |
MONKEYPOX |
32 |
0.1159 |
| 47 |
ACQUIRED GENE MUTATION |
149 |
0.1137 |
| 48 |
RENAL TUBULAR DYSFUNCTION |
64 |
0.1133 |
| 49 |
HIV INFECTION |
336 |
0.1114 |
| 50 |
CHRONIC HEPATITIS B |
35 |
0.1104 |
| 51 |
HYPOPHOSPHATAEMIC OSTEOMALACIA |
29 |
0.1098 |
| 52 |
ACUTE HEPATITIS B |
36 |
0.1084 |
| 53 |
HYPOURICAEMIA |
31 |
0.1069 |
| 54 |
TRISOMY 21 |
134 |
0.1063 |
| 55 |
CONGENITAL HYDROCEPHALUS |
53 |
0.1045 |
| 56 |
STILLBIRTH |
492 |
0.1017 |
| 57 |
ANAEMIA NEONATAL |
49 |
0.1017 |
| 58 |
HYDROPS FOETALIS |
62 |
0.1011 |
| 59 |
SYPHILIS |
73 |
0.1004 |
| 60 |
FOETAL EXPOSURE DURING DELIVERY |
63 |
0.0929 |
| 61 |
NEURAL TUBE DEFECT |
67 |
0.0922 |
| 62 |
MENINGITIS CRYPTOCOCCAL |
161 |
0.0920 |
| 63 |
PLAGIOCEPHALY |
44 |
0.0882 |
| 64 |
DRUG RESISTANCE |
2228 |
0.0866 |
| 65 |
VIRAEMIA |
119 |
0.0859 |
| 66 |
NODULAR REGENERATIVE HYPERPLASIA |
55 |
0.0857 |
| 67 |
EXOMPHALOS |
45 |
0.0838 |
| 68 |
CUSHING'S SYNDROME |
58 |
0.0835 |
| 69 |
PSYCHIATRIC DECOMPENSATION |
161 |
0.0823 |
| 70 |
ATRIOVENTRICULAR SEPTAL DEFECT |
38 |
0.0809 |
| 71 |
LIPOHYPERTROPHY |
50 |
0.0804 |
| 72 |
MULTIPLE-DRUG RESISTANCE |
230 |
0.0741 |
| 73 |
INTRA-UTERINE DEATH |
116 |
0.0722 |
| 74 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
78 |
0.0721 |
| 75 |
MENINGITIS TUBERCULOUS |
39 |
0.0698 |
| 76 |
CEREBRAL TOXOPLASMOSIS |
65 |
0.0696 |
| 77 |
GASTROSCHISIS |
33 |
0.0693 |
| 78 |
PORTAL HYPERTENSIVE GASTROPATHY |
39 |
0.0691 |
| 79 |
MALARIA |
48 |
0.0681 |
| 80 |
HYPERLACTACIDAEMIA |
179 |
0.0667 |
| 81 |
CYTOMEGALOVIRUS CHORIORETINITIS |
130 |
0.0666 |
| 82 |
GENE MUTATION |
129 |
0.0651 |
| 83 |
CONGENITAL FOOT MALFORMATION |
28 |
0.0617 |
| 84 |
RETINAL TOXICITY |
63 |
0.0612 |
| 85 |
FOETAL GROWTH RETARDATION |
47 |
0.0600 |
| 86 |
DISSEMINATED BACILLUS CALMETTE-GUERIN INFECTION |
28 |
0.0600 |
| 87 |
ANAEMIA MACROCYTIC |
127 |
0.0595 |
| 88 |
PORTAL HYPERTENSION |
183 |
0.0593 |
| 89 |
CONGENITAL HYDRONEPHROSIS |
42 |
0.0587 |
| 90 |
GLYCOSURIA |
79 |
0.0584 |
| 91 |
EAR MALFORMATION |
27 |
0.0583 |
| 92 |
RENAL TUBULAR DISORDER |
163 |
0.0579 |
| 93 |
ANHEDONIA |
1456 |
0.0554 |
| 94 |
CRYPTOCOCCOSIS |
90 |
0.0552 |
| 95 |
UMBILICAL CORD ABNORMALITY |
29 |
0.0550 |
| 96 |
NEONATAL DISORDER |
87 |
0.0549 |
| 97 |
NEURODEVELOPMENTAL DISORDER |
37 |
0.0547 |
| 98 |
ARNOLD-CHIARI MALFORMATION |
52 |
0.0545 |
| 99 |
DEATH NEONATAL |
74 |
0.0532 |
| 100 |
BLOOD LACTIC ACID INCREASED |
280 |
0.0531 |
| 101 |
VISCERAL LEISHMANIASIS |
38 |
0.0526 |
| 102 |
LYMPH NODE TUBERCULOSIS |
39 |
0.0524 |
| 103 |
ALPHA 1 FOETOPROTEIN INCREASED |
37 |
0.0520 |
| 104 |
HIV TEST POSITIVE |
34 |
0.0514 |
| 105 |
FOETAL DEATH |
266 |
0.0512 |
| 106 |
PSYCHOMOTOR SKILLS IMPAIRED |
134 |
0.0511 |
| 107 |
PREMATURE RUPTURE OF MEMBRANES |
123 |
0.0510 |
| 108 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
37 |
0.0510 |
| 109 |
DRUG EXPOSURE DURING PREGNANCY |
1708 |
0.0502 |
| 110 |
CLEFT LIP AND PALATE |
56 |
0.0501 |
| 111 |
SKULL MALFORMATION |
32 |
0.0498 |
| 112 |
HEPATITIS A |
42 |
0.0495 |
| 113 |
OPHTHALMOPLEGIA |
77 |
0.0488 |
| 114 |
PLACENTAL DISORDER |
46 |
0.0486 |
| 115 |
CRYPTORCHISM |
54 |
0.0481 |
| 116 |
TEMPERATURE REGULATION DISORDER |
105 |
0.0471 |
| 117 |
HYPERTRIGLYCERIDAEMIA |
274 |
0.0468 |
| 118 |
ABORTION INDUCED |
435 |
0.0462 |
| 119 |
DYSLIPIDAEMIA |
233 |
0.0458 |
| 120 |
HEPATIC FIBROSIS |
153 |
0.0445 |
| 121 |
MACROCYTOSIS |
51 |
0.0440 |
| 122 |
PYELOCALIECTASIS |
42 |
0.0438 |
| 123 |
PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT |
38 |
0.0435 |
| 124 |
JAUNDICE CHOLESTATIC |
153 |
0.0433 |
| 125 |
SPINA BIFIDA |
90 |
0.0432 |
| 126 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
115 |
0.0428 |
| 127 |
VARICES OESOPHAGEAL |
125 |
0.0413 |
| 128 |
DEPRESSIVE SYMPTOM |
145 |
0.0411 |
| 129 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
45 |
0.0409 |
| 130 |
HEPATOSPLENOMEGALY |
105 |
0.0409 |
| 131 |
CEREBRAL VENTRICLE DILATATION |
47 |
0.0408 |
| 132 |
HYPOMANIA |
149 |
0.0405 |
| 133 |
TOXOPLASMOSIS |
43 |
0.0398 |
| 134 |
OESOPHAGEAL VARICES HAEMORRHAGE |
86 |
0.0396 |
| 135 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
86 |
0.0386 |
| 136 |
RENAL TUBULAR ACIDOSIS |
83 |
0.0380 |
| 137 |
FAT TISSUE INCREASED |
55 |
0.0379 |
| 138 |
LIVE BIRTH |
315 |
0.0376 |
| 139 |
PLACENTAL INSUFFICIENCY |
30 |
0.0374 |
| 140 |
ECONOMIC PROBLEM |
566 |
0.0373 |
| 141 |
DEPRESSION SUICIDAL |
128 |
0.0369 |
| 142 |
TWIN PREGNANCY |
31 |
0.0369 |
| 143 |
LIMB MALFORMATION |
29 |
0.0368 |
| 144 |
OSTEOPENIA |
557 |
0.0367 |
| 145 |
HYDROCELE |
39 |
0.0366 |
| 146 |
VANISHING BILE DUCT SYNDROME |
40 |
0.0359 |
| 147 |
HYPOPHOSPHATAEMIA |
265 |
0.0358 |
| 148 |
BLOOD AMYLASE INCREASED |
61 |
0.0356 |
| 149 |
PULMONARY TUBERCULOSIS |
152 |
0.0355 |
| 150 |
FOETAL EXPOSURE DURING PREGNANCY |
2841 |
0.0349 |
| 151 |
CAESAREAN SECTION |
404 |
0.0347 |
| 152 |
POLYHYDRAMNIOS |
35 |
0.0343 |
| 153 |
BONE MARROW TOXICITY |
40 |
0.0338 |
| 154 |
TEARFULNESS |
143 |
0.0332 |
| 155 |
MYCOBACTERIAL INFECTION |
56 |
0.0325 |
| 156 |
HISTOPLASMOSIS |
57 |
0.0322 |
| 157 |
FOETAL DISTRESS SYNDROME |
68 |
0.0320 |
| 158 |
EXPOSURE DURING BREAST FEEDING |
106 |
0.0320 |
| 159 |
MICROCEPHALY |
41 |
0.0320 |
| 160 |
CALCULUS URINARY |
49 |
0.0318 |
| 161 |
HYPOSPADIAS |
65 |
0.0312 |
| 162 |
FOETAL GROWTH RESTRICTION |
187 |
0.0307 |
| 163 |
PORTAL VEIN THROMBOSIS |
99 |
0.0306 |
| 164 |
VENTRICULAR SEPTAL DEFECT |
174 |
0.0304 |
| 165 |
FOETAL HEART RATE ABNORMAL |
28 |
0.0302 |
| 166 |
NEPHRITIS INTERSTITIAL |
38 |
0.0300 |
| 167 |
TALIPES |
92 |
0.0296 |
| 168 |
SMALL FOR DATES BABY |
147 |
0.0296 |
| 169 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
31 |
0.0292 |
| 170 |
MATERNAL DRUGS AFFECTING FOETUS |
224 |
0.0292 |
| 171 |
CYTOLYTIC HEPATITIS |
94 |
0.0283 |
| 172 |
PREMATURE BABY |
851 |
0.0282 |
| 173 |
PREMATURE SEPARATION OF PLACENTA |
43 |
0.0279 |
| 174 |
NON-HODGKIN'S LYMPHOMA |
36 |
0.0275 |
| 175 |
PREMATURE LABOUR |
152 |
0.0269 |
| 176 |
PRE-ECLAMPSIA |
127 |
0.0267 |
| 177 |
HEPATORENAL SYNDROME |
45 |
0.0266 |
| 178 |
VOLVULUS |
63 |
0.0266 |
| 179 |
ATYPICAL MYCOBACTERIAL INFECTION |
37 |
0.0261 |
| 180 |
LOW BIRTH WEIGHT BABY |
206 |
0.0259 |
| 181 |
NEPHROPATHY TOXIC |
291 |
0.0259 |
| 182 |
HEPATOCELLULAR CARCINOMA |
194 |
0.0255 |
| 183 |
HEPATIC NEOPLASM MALIGNANT |
54 |
0.0255 |
| 184 |
PREGNANCY ON CONTRACEPTIVE |
37 |
0.0253 |
| 185 |
CARDIAC MURMUR |
219 |
0.0253 |
| 186 |
HYPOPROTEINAEMIA |
48 |
0.0253 |
| 187 |
NECROTISING COLITIS |
32 |
0.0252 |
| 188 |
LYMPHADENITIS |
61 |
0.0252 |
| 189 |
RHINITIS ALLERGIC |
112 |
0.0251 |
| 190 |
OESOPHAGEAL CANDIDIASIS |
98 |
0.0246 |
| 191 |
LIVER TRANSPLANT REJECTION |
44 |
0.0245 |
| 192 |
DISSEMINATED TUBERCULOSIS |
62 |
0.0241 |
| 193 |
ABORTION SPONTANEOUS |
964 |
0.0240 |
| 194 |
CACHEXIA |
123 |
0.0239 |
| 195 |
BLOOD PHOSPHORUS DECREASED |
87 |
0.0238 |
| 196 |
BLOOD BICARBONATE DECREASED |
45 |
0.0237 |
| 197 |
LIVER TRANSPLANT |
84 |
0.0231 |
| 198 |
HEPATIC ENCEPHALOPATHY |
215 |
0.0230 |
| 199 |
SARCOIDOSIS |
109 |
0.0229 |
| 200 |
DYSMORPHISM |
54 |
0.0229 |
| 201 |
STRONGYLOIDIASIS |
37 |
0.0229 |
| 202 |
OSTEOPOROSIS |
940 |
0.0228 |
| 203 |
NORMAL NEWBORN |
124 |
0.0228 |
| 204 |
HYPERBILIRUBINAEMIA |
232 |
0.0224 |
| 205 |
ATRIAL SEPTAL DEFECT |
186 |
0.0222 |
| 206 |
OPPORTUNISTIC INFECTION |
41 |
0.0222 |
| 207 |
EYELID PTOSIS |
225 |
0.0221 |
| 208 |
HEPATOMEGALY |
217 |
0.0221 |
| 209 |
HYPERPHOSPHATAEMIA |
47 |
0.0218 |
| 210 |
SPEECH DISORDER DEVELOPMENTAL |
62 |
0.0216 |
| 211 |
HEPATITIS E |
34 |
0.0215 |
| 212 |
POSTPARTUM HAEMORRHAGE |
29 |
0.0215 |
| 213 |
BONE DENSITY DECREASED |
672 |
0.0214 |
| 214 |
EXPOSURE DURING PREGNANCY |
1333 |
0.0214 |
| 215 |
NASAL POLYPS |
105 |
0.0213 |
| 216 |
GLUCOSE URINE PRESENT |
27 |
0.0212 |
| 217 |
RENAL COLIC |
48 |
0.0212 |
| 218 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
75 |
0.0212 |
| 219 |
PATENT DUCTUS ARTERIOSUS |
84 |
0.0211 |
| 220 |
HEPATOTOXICITY |
466 |
0.0209 |
| 221 |
GENITAL HERPES |
32 |
0.0209 |
| 222 |
PREGNANCY |
408 |
0.0204 |
| 223 |
SCHIZOPHRENIA |
242 |
0.0199 |
| 224 |
OSTEOPOROTIC FRACTURE |
38 |
0.0198 |
| 225 |
OPTIC NEUROPATHY |
42 |
0.0198 |
| 226 |
END STAGE RENAL DISEASE |
359 |
0.0197 |
| 227 |
HEPATITIS FULMINANT |
58 |
0.0195 |
| 228 |
BLOOD BILIRUBIN INCREASED |
522 |
0.0193 |
| 229 |
PSYCHOMOTOR RETARDATION |
54 |
0.0192 |
| 230 |
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY |
157 |
0.0190 |
| 231 |
HEPATITIS C |
229 |
0.0189 |
| 232 |
HEPATIC FAILURE |
569 |
0.0189 |
| 233 |
HEPATIC NECROSIS |
71 |
0.0188 |
| 234 |
BILIRUBIN CONJUGATED INCREASED |
44 |
0.0188 |
| 235 |
HYPERPARATHYROIDISM SECONDARY |
47 |
0.0187 |
| 236 |
PROTEINURIA |
356 |
0.0187 |
| 237 |
PREMATURE DELIVERY |
296 |
0.0186 |
| 238 |
OPTIC ATROPHY |
30 |
0.0184 |
| 239 |
STRABISMUS |
54 |
0.0184 |
| 240 |
CEREBELLAR SYNDROME |
40 |
0.0182 |
| 241 |
HYDROCEPHALUS |
99 |
0.0182 |
| 242 |
ECTOPIC PREGNANCY |
54 |
0.0175 |
| 243 |
HYPERURICAEMIA |
72 |
0.0175 |
| 244 |
BRONCHIECTASIS |
118 |
0.0175 |
| 245 |
HEPATIC CIRRHOSIS |
323 |
0.0172 |
| 246 |
HYPERLIPIDAEMIA |
205 |
0.0171 |
| 247 |
CUSHINGOID |
55 |
0.0171 |
| 248 |
HYPERPARATHYROIDISM |
35 |
0.0170 |
| 249 |
HEPATITIS CHOLESTATIC |
102 |
0.0169 |
| 250 |
TREATMENT NONCOMPLIANCE |
924 |
0.0169 |
| 251 |
HAEMANGIOMA |
39 |
0.0169 |
| 252 |
OLIGOHYDRAMNIOS |
56 |
0.0168 |
| 253 |
CONGENITAL ANOMALY |
129 |
0.0166 |
| 254 |
SPLENOMEGALY |
194 |
0.0165 |
| 255 |
JAUNDICE |
445 |
0.0165 |
| 256 |
HEPATITIS TOXIC |
42 |
0.0161 |
| 257 |
CHRONIC KIDNEY DISEASE |
1217 |
0.0160 |
| 258 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
52 |
0.0157 |
| 259 |
GESTATIONAL DIABETES |
75 |
0.0157 |
| 260 |
BRAIN HERNIATION |
47 |
0.0157 |
| 261 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
51 |
0.0157 |
| 262 |
HEPATITIS |
401 |
0.0157 |
| 263 |
PROTEIN URINE PRESENT |
78 |
0.0156 |
| 264 |
NEPHROPATHY |
145 |
0.0155 |
| 265 |
OCULAR ICTERUS |
67 |
0.0154 |
| 266 |
APLASIA PURE RED CELL |
53 |
0.0154 |
| 267 |
MULTIPLE FRACTURES |
246 |
0.0150 |
| 268 |
LIPIDS INCREASED |
30 |
0.0149 |
| 269 |
GRANULOMA |
51 |
0.0147 |
| 270 |
HEART DISEASE CONGENITAL |
52 |
0.0147 |
| 271 |
CLEFT PALATE |
28 |
0.0145 |
| 272 |
RENAL TRANSPLANT |
52 |
0.0144 |
| 273 |
FOOD ALLERGY |
110 |
0.0142 |
| 274 |
LIPASE INCREASED |
109 |
0.0142 |
| 275 |
RENAL IMPAIRMENT |
1193 |
0.0142 |
| 276 |
ALANINE AMINOTRANSFERASE INCREASED |
871 |
0.0142 |
| 277 |
DRUG INTERACTION |
2193 |
0.0138 |
| 278 |
LACTIC ACIDOSIS |
446 |
0.0138 |
| 279 |
TREATMENT FAILURE |
1131 |
0.0136 |
| 280 |
EMOTIONAL DISTRESS |
1636 |
0.0135 |
| 281 |
CHOLESTATIC LIVER INJURY |
30 |
0.0135 |
| 282 |
ASCITES |
390 |
0.0133 |
| 283 |
ASPARTATE AMINOTRANSFERASE INCREASED |
699 |
0.0131 |
| 284 |
ENCEPHALITIS |
91 |
0.0131 |
| 285 |
BLOOD CREATININE INCREASED |
856 |
0.0131 |
| 286 |
TRANSAMINASES INCREASED |
289 |
0.0130 |
| 287 |
DRUG-INDUCED LIVER INJURY |
405 |
0.0129 |
| 288 |
DECREASED ACTIVITY |
139 |
0.0129 |
| 289 |
QUALITY OF LIFE DECREASED |
172 |
0.0128 |
| 290 |
HYPOALBUMINAEMIA |
99 |
0.0127 |
| 291 |
PSYCHOTIC DISORDER |
375 |
0.0127 |
| 292 |
BLOOD URIC ACID INCREASED |
73 |
0.0126 |
| 293 |
GLOMERULAR FILTRATION RATE DECREASED |
155 |
0.0126 |
| 294 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
278 |
0.0125 |
| 295 |
CREATININE RENAL CLEARANCE DECREASED |
50 |
0.0125 |
| 296 |
HISTIOCYTOSIS HAEMATOPHAGIC |
37 |
0.0124 |
| 297 |
AREFLEXIA |
33 |
0.0124 |
| 298 |
MATERNAL EXPOSURE DURING PREGNANCY |
1097 |
0.0123 |
| 299 |
RENAL TUBULAR NECROSIS |
119 |
0.0121 |
| 300 |
ORAL CANDIDIASIS |
158 |
0.0120 |
| 301 |
PARADOXICAL DRUG REACTION |
44 |
0.0119 |
| 302 |
POLYOMAVIRUS-ASSOCIATED NEPHROPATHY |
28 |
0.0119 |
| 303 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
294 |
0.0118 |
| 304 |
OSTEONECROSIS |
385 |
0.0117 |
| 305 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
562 |
0.0117 |
| 306 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
33 |
0.0116 |
| 307 |
ACUTE HEPATIC FAILURE |
158 |
0.0116 |
| 308 |
HYPERTONIA |
66 |
0.0115 |
| 309 |
LUNG NEOPLASM |
49 |
0.0115 |
| 310 |
STEVENS-JOHNSON SYNDROME |
254 |
0.0114 |
| 311 |
LYMPHADENOPATHY |
403 |
0.0114 |
| 312 |
VITAMIN D DEFICIENCY |
110 |
0.0113 |
| 313 |
CONGESTIVE CARDIOMYOPATHY |
47 |
0.0113 |
| 314 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
178 |
0.0112 |
| 315 |
TRANSPLANT REJECTION |
88 |
0.0110 |
| 316 |
BK VIRUS INFECTION |
37 |
0.0110 |
| 317 |
MIXED LIVER INJURY |
33 |
0.0110 |
| 318 |
HYDRONEPHROSIS |
82 |
0.0109 |
| 319 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
46 |
0.0109 |
| 320 |
BONE LOSS |
162 |
0.0108 |
| 321 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
108 |
0.0107 |
| 322 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
308 |
0.0107 |
| 323 |
LUNG ADENOCARCINOMA |
32 |
0.0106 |
| 324 |
BLOOD TRIGLYCERIDES INCREASED |
184 |
0.0104 |
| 325 |
CYTOMEGALOVIRUS INFECTION |
173 |
0.0104 |
| 326 |
FEMORAL NECK FRACTURE |
53 |
0.0103 |
| 327 |
HYPERCHOLESTEROLAEMIA |
99 |
0.0102 |
| 328 |
HEPATIC FUNCTION ABNORMAL |
382 |
0.0102 |
| 329 |
HEPATITIS ACUTE |
66 |
0.0101 |
| 330 |
NEPHROGENIC ANAEMIA |
47 |
0.0101 |
| 331 |
FIBROSIS |
31 |
0.0101 |
| 332 |
MYOPATHY |
87 |
0.0101 |
| 333 |
CHOLELITHIASIS |
328 |
0.0100 |
| 334 |
CHOLESTASIS |
191 |
0.0099 |
| 335 |
RENAL FAILURE |
1318 |
0.0099 |
| 336 |
STAPHYLOCOCCAL SEPSIS |
49 |
0.0099 |
| 337 |
INTRACRANIAL PRESSURE INCREASED |
55 |
0.0099 |
| 338 |
IMMUNODEFICIENCY |
147 |
0.0099 |
| 339 |
PRESCRIBED OVERDOSE |
190 |
0.0098 |
| 340 |
COELIAC DISEASE |
96 |
0.0098 |
| 341 |
HEPATIC STEATOSIS |
182 |
0.0098 |
| 342 |
DRUG TOXICITY |
133 |
0.0098 |
| 343 |
BLOOD CREATINE INCREASED |
43 |
0.0097 |
| 344 |
UMBILICAL HERNIA |
45 |
0.0096 |
| 345 |
ANOREXIA |
124 |
0.0096 |
| 346 |
DERMATITIS EXFOLIATIVE |
48 |
0.0096 |
| 347 |
HERPES VIRUS INFECTION |
55 |
0.0095 |
| 348 |
EXPOSURE VIA BREAST MILK |
38 |
0.0095 |
| 349 |
AUTOIMMUNE THYROIDITIS |
36 |
0.0095 |
| 350 |
ELECTROENCEPHALOGRAM ABNORMAL |
30 |
0.0095 |
| 351 |
METABOLIC DISORDER |
55 |
0.0095 |
| 352 |
PATHOLOGICAL FRACTURE |
48 |
0.0094 |
| 353 |
PRODUCT DOSE OMISSION IN ERROR |
266 |
0.0094 |
| 354 |
HERPES SIMPLEX |
61 |
0.0094 |
| 355 |
TOXIC EPIDERMAL NECROLYSIS |
142 |
0.0093 |
| 356 |
AUTOIMMUNE HEPATITIS |
65 |
0.0093 |
| 357 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
32 |
0.0093 |
| 358 |
BLOOD ALBUMIN DECREASED |
74 |
0.0093 |
| 359 |
HYPOTONIA |
93 |
0.0093 |
| 360 |
PARANOIA |
160 |
0.0093 |
| 361 |
RASH MACULO-PAPULAR |
206 |
0.0093 |
| 362 |
METABOLIC ACIDOSIS |
296 |
0.0092 |
| 363 |
GASTROENTERITIS |
132 |
0.0090 |
| 364 |
HAEMOLYTIC ANAEMIA |
81 |
0.0090 |
| 365 |
HAND FRACTURE |
64 |
0.0090 |
| 366 |
CANDIDIASIS |
36 |
0.0090 |
| 367 |
ANAEMIA |
1709 |
0.0090 |
| 368 |
NEUROLOGICAL SYMPTOM |
51 |
0.0089 |
| 369 |
POLYNEUROPATHY |
106 |
0.0088 |
| 370 |
APLASTIC ANAEMIA |
46 |
0.0088 |
| 371 |
TOOTH LOSS |
182 |
0.0088 |
| 372 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
65 |
0.0087 |
| 373 |
HEPATIC CYTOLYSIS |
110 |
0.0086 |
| 374 |
HEPATIC ENZYME INCREASED |
584 |
0.0086 |
| 375 |
TACHYPNOEA |
116 |
0.0085 |
| 376 |
PANCYTOPENIA |
471 |
0.0084 |
| 377 |
ATAXIA |
100 |
0.0084 |
| 378 |
LYMPHOMA |
130 |
0.0084 |
| 379 |
MULTI-ORGAN FAILURE |
145 |
0.0084 |
| 380 |
BURSITIS |
101 |
0.0083 |
| 381 |
LEUKOENCEPHALOPATHY |
31 |
0.0083 |
| 382 |
RENAL FAILURE ACUTE |
350 |
0.0082 |
| 383 |
CORONARY ARTERY STENOSIS |
41 |
0.0081 |
| 384 |
FOOT FRACTURE |
153 |
0.0081 |
| 385 |
DEPRESSION |
1826 |
0.0080 |
| 386 |
DEVELOPMENTAL DELAY |
72 |
0.0080 |
| 387 |
DISSEMINATED INTRAVASCULAR COAGULATION |
111 |
0.0079 |
| 388 |
NEPHROTIC SYNDROME |
54 |
0.0079 |
| 389 |
CEREBRAL ATROPHY |
31 |
0.0078 |
| 390 |
LOW DENSITY LIPOPROTEIN INCREASED |
60 |
0.0077 |
| 391 |
NECROSIS |
43 |
0.0077 |
| 392 |
ENTEROCOCCAL INFECTION |
37 |
0.0076 |
| 393 |
DIPLOPIA |
198 |
0.0076 |
| 394 |
SPINAL COMPRESSION FRACTURE |
63 |
0.0076 |
| 395 |
LEUKOPENIA |
381 |
0.0076 |
| 396 |
ACIDOSIS |
58 |
0.0076 |
| 397 |
RENAL INJURY |
225 |
0.0076 |
| 398 |
SKELETAL INJURY |
77 |
0.0074 |
| 399 |
EPSTEIN-BARR VIRUS INFECTION |
46 |
0.0074 |
| 400 |
FAILURE TO THRIVE |
38 |
0.0073 |
| 401 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
32 |
0.0072 |
| 402 |
MENINGITIS |
48 |
0.0072 |
| 403 |
BENIGN PROSTATIC HYPERPLASIA |
37 |
0.0072 |
| 404 |
ADRENAL INSUFFICIENCY |
86 |
0.0071 |
| 405 |
TIBIA FRACTURE |
33 |
0.0070 |
| 406 |
LEFT VENTRICULAR DYSFUNCTION |
47 |
0.0070 |
| 407 |
ABDOMINAL HERNIA |
32 |
0.0070 |
| 408 |
BRONCHOPULMONARY ASPERGILLOSIS |
54 |
0.0070 |
| 409 |
NEUROTOXICITY |
122 |
0.0070 |
| 410 |
ILEUS PARALYTIC |
31 |
0.0069 |
| 411 |
ANXIETY |
1975 |
0.0069 |
| 412 |
BONE MARROW FAILURE |
141 |
0.0069 |
| 413 |
PAPILLOEDEMA |
31 |
0.0069 |
| 414 |
DRUG LEVEL INCREASED |
113 |
0.0068 |
| 415 |
GLUCOSE TOLERANCE IMPAIRED |
40 |
0.0068 |
| 416 |
PNEUMONIA BACTERIAL |
62 |
0.0067 |
| 417 |
DRUG LEVEL BELOW THERAPEUTIC |
37 |
0.0067 |
| 418 |
PRODUCT DOSE OMISSION ISSUE |
1965 |
0.0067 |
| 419 |
RENAL CYST |
53 |
0.0067 |
| 420 |
LIVER FUNCTION TEST ABNORMAL |
194 |
0.0067 |
| 421 |
RIB FRACTURE |
136 |
0.0066 |
| 422 |
EXERCISE TOLERANCE DECREASED |
38 |
0.0066 |
| 423 |
ENCEPHALOPATHY |
161 |
0.0065 |
| 424 |
THROMBOCYTOPENIA |
726 |
0.0065 |
| 425 |
COAGULOPATHY |
108 |
0.0065 |
| 426 |
NEPHROLITHIASIS |
297 |
0.0065 |
| 427 |
TORSADE DE POINTES |
50 |
0.0064 |
| 428 |
LIVER INJURY |
156 |
0.0063 |
| 429 |
PROTHROMBIN TIME PROLONGED |
38 |
0.0063 |
| 430 |
IMMUNE THROMBOCYTOPENIA |
29 |
0.0063 |
| 431 |
MALABSORPTION |
33 |
0.0063 |
| 432 |
HEPATOCELLULAR INJURY |
89 |
0.0063 |
| 433 |
HEMIPLEGIA |
52 |
0.0062 |
| 434 |
PYELONEPHRITIS |
54 |
0.0062 |
| 435 |
LIVER DISORDER |
276 |
0.0062 |
| 436 |
PURPURA |
55 |
0.0062 |
| 437 |
NERVOUS SYSTEM DISORDER |
194 |
0.0062 |
| 438 |
MALNUTRITION |
69 |
0.0062 |
| 439 |
ANGINA UNSTABLE |
40 |
0.0061 |
| 440 |
MYOSITIS |
55 |
0.0061 |
| 441 |
HYPOKALAEMIA |
280 |
0.0061 |
| 442 |
PANCREATITIS ACUTE |
136 |
0.0060 |
| 443 |
TUBULOINTERSTITIAL NEPHRITIS |
113 |
0.0060 |
| 444 |
HYPERKALAEMIA |
211 |
0.0060 |
| 445 |
LUNG INFILTRATION |
53 |
0.0060 |
| 446 |
GUILLAIN-BARRE SYNDROME |
29 |
0.0060 |
| 447 |
CHOLANGITIS |
37 |
0.0060 |
| 448 |
RESPIRATORY DISTRESS |
164 |
0.0059 |
| 449 |
LYMPHOCYTE COUNT DECREASED |
105 |
0.0059 |
| 450 |
KLEBSIELLA INFECTION |
30 |
0.0059 |
| 451 |
ACUTE KIDNEY INJURY |
901 |
0.0059 |
| 452 |
DERMATITIS ALLERGIC |
74 |
0.0059 |
| 453 |
RALES |
34 |
0.0058 |
| 454 |
WRIST FRACTURE |
70 |
0.0058 |
| 455 |
NEUTROPENIA |
793 |
0.0058 |
| 456 |
RHINITIS |
47 |
0.0058 |
| 457 |
PANCREATITIS |
308 |
0.0058 |
| 458 |
HYPOCALCAEMIA |
109 |
0.0058 |
| 459 |
HYPERTRANSAMINASAEMIA |
40 |
0.0057 |
| 460 |
HAEMOLYSIS |
44 |
0.0057 |
| 461 |
IMMUNOSUPPRESSION |
50 |
0.0057 |
| 462 |
SEPTIC SHOCK |
245 |
0.0056 |
| 463 |
GRANULOCYTOPENIA |
32 |
0.0056 |
| 464 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
159 |
0.0056 |
| 465 |
PYREXIA |
1942 |
0.0056 |
| 466 |
RENAL FAILURE CHRONIC |
43 |
0.0056 |
| 467 |
EYELID OEDEMA |
65 |
0.0056 |
| 468 |
BRAIN OEDEMA |
70 |
0.0055 |
| 469 |
VISUAL FIELD DEFECT |
40 |
0.0055 |
| 470 |
ATRIOVENTRICULAR BLOCK COMPLETE |
37 |
0.0055 |
| 471 |
AGRANULOCYTOSIS |
102 |
0.0055 |
| 472 |
RENAL PAIN |
58 |
0.0055 |
| 473 |
CHOLECYSTITIS ACUTE |
31 |
0.0055 |
| 474 |
HYPERTHYROIDISM |
79 |
0.0055 |
| 475 |
RENAL DISORDER |
254 |
0.0054 |
| 476 |
ABDOMINAL TENDERNESS |
27 |
0.0054 |
| 477 |
BACTERAEMIA |
64 |
0.0054 |
| 478 |
HEMIPARESIS |
91 |
0.0054 |
| 479 |
ACUTE MYOCARDIAL INFARCTION |
158 |
0.0054 |
| 480 |
DRUG ERUPTION |
94 |
0.0053 |
| 481 |
NYSTAGMUS |
28 |
0.0053 |
| 482 |
DYSSTASIA |
154 |
0.0053 |
| 483 |
ANURIA |
45 |
0.0052 |
| 484 |
RHABDOMYOLYSIS |
218 |
0.0052 |
| 485 |
DRUG LEVEL DECREASED |
53 |
0.0052 |
| 486 |
ODYNOPHAGIA |
31 |
0.0052 |
| 487 |
NEUTROPENIC SEPSIS |
37 |
0.0052 |
| 488 |
BEHAVIOUR DISORDER |
28 |
0.0052 |
| 489 |
HAEMATOTOXICITY |
49 |
0.0052 |
| 490 |
MUSCLE ATROPHY |
64 |
0.0050 |
| 491 |
INTENTIONAL DOSE OMISSION |
144 |
0.0050 |
| 492 |
ANKLE FRACTURE |
78 |
0.0050 |
| 493 |
FEBRILE NEUTROPENIA |
331 |
0.0050 |
| 494 |
PLATELET COUNT INCREASED |
65 |
0.0050 |
| 495 |
INTERVERTEBRAL DISC DEGENERATION |
46 |
0.0050 |
| 496 |
BOWEL MOVEMENT IRREGULARITY |
38 |
0.0050 |
| 497 |
DIABETES MELLITUS |
378 |
0.0050 |
| 498 |
CARDIOMYOPATHY |
73 |
0.0049 |
| 499 |
DIFFUSE LARGE B-CELL LYMPHOMA |
38 |
0.0049 |
| 500 |
LYMPHOEDEMA |
34 |
0.0049 |
| 501 |
EOSINOPHILIA |
86 |
0.0049 |
| 502 |
SKIN LESION |
134 |
0.0049 |
| 503 |
POLYURIA |
40 |
0.0049 |
| 504 |
CHROMATURIA |
110 |
0.0049 |
| 505 |
DERMATITIS BULLOUS |
35 |
0.0048 |
| 506 |
CENTRAL NERVOUS SYSTEM LESION |
66 |
0.0048 |
| 507 |
NEUROPATHY PERIPHERAL |
455 |
0.0048 |
| 508 |
CARDIOMEGALY |
58 |
0.0047 |
| 509 |
HAEMODIALYSIS |
39 |
0.0046 |
| 510 |
CHOLECYSTITIS |
55 |
0.0046 |
| 511 |
NEUTROPHIL COUNT DECREASED |
187 |
0.0046 |
| 512 |
TOXIC SKIN ERUPTION |
46 |
0.0046 |
| 513 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
78 |
0.0045 |
| 514 |
PSEUDOMONAS INFECTION |
39 |
0.0045 |
| 515 |
CLOSTRIDIUM DIFFICILE COLITIS |
48 |
0.0045 |
| 516 |
FACE OEDEMA |
76 |
0.0045 |
| 517 |
GASTRITIS |
118 |
0.0045 |
| 518 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
79 |
0.0045 |
| 519 |
PULMONARY HYPERTENSION |
93 |
0.0045 |
| 520 |
SPINAL OSTEOARTHRITIS |
39 |
0.0044 |
| 521 |
HYPERGLYCAEMIA |
161 |
0.0044 |
| 522 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
39 |
0.0044 |
| 523 |
PLATELET COUNT DECREASED |
467 |
0.0044 |
| 524 |
MAJOR DEPRESSION |
32 |
0.0044 |
| 525 |
VASCULITIS |
51 |
0.0044 |
| 526 |
APPETITE DISORDER |
29 |
0.0044 |
| 527 |
FLANK PAIN |
41 |
0.0044 |
| 528 |
INABILITY TO AFFORD MEDICATION |
43 |
0.0043 |
| 529 |
SKIN HYPERPIGMENTATION |
37 |
0.0043 |
| 530 |
SINUS TACHYCARDIA |
61 |
0.0043 |
| 531 |
RASH ERYTHEMATOUS |
205 |
0.0043 |
| 532 |
FRACTURE |
81 |
0.0043 |
| 533 |
SKIN PLAQUE |
36 |
0.0043 |
| 534 |
PALLOR |
116 |
0.0043 |
| 535 |
PAPULE |
30 |
0.0043 |
| 536 |
RESPIRATORY FAILURE |
310 |
0.0042 |
| 537 |
DIALYSIS |
60 |
0.0042 |
| 538 |
GRAND MAL CONVULSION |
39 |
0.0042 |
| 539 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
71 |
0.0042 |
| 540 |
SEPSIS |
469 |
0.0042 |
| 541 |
CONTRAINDICATED PRODUCT ADMINISTERED |
127 |
0.0042 |
| 542 |
MYOCARDITIS |
48 |
0.0042 |
| 543 |
DECREASED IMMUNE RESPONSIVENESS |
41 |
0.0042 |
| 544 |
STATUS EPILEPTICUS |
47 |
0.0042 |
| 545 |
MITRAL VALVE INCOMPETENCE |
47 |
0.0041 |
| 546 |
COVID-19 PNEUMONIA |
49 |
0.0041 |
| 547 |
RASH GENERALISED |
107 |
0.0041 |
| 548 |
LYMPHOPENIA |
58 |
0.0041 |
| 549 |
SUDDEN DEATH |
43 |
0.0041 |
| 550 |
RESPIRATORY RATE INCREASED |
36 |
0.0041 |
| 551 |
SPINAL FRACTURE |
81 |
0.0040 |
| 552 |
ESCHERICHIA INFECTION |
33 |
0.0040 |
| 553 |
CONJUNCTIVITIS |
74 |
0.0040 |
| 554 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
38 |
0.0040 |
| 555 |
IMPAIRED WORK ABILITY |
85 |
0.0040 |
| 556 |
GENERALISED OEDEMA |
49 |
0.0040 |
| 557 |
ARTERIOSCLEROSIS |
37 |
0.0039 |
| 558 |
DISEASE RECURRENCE |
186 |
0.0039 |
| 559 |
ABSCESS |
62 |
0.0039 |
| 560 |
BLOOD UREA INCREASED |
65 |
0.0039 |
| 561 |
HAEMATEMESIS |
98 |
0.0039 |
| 562 |
ERYTHEMA MULTIFORME |
36 |
0.0039 |
| 563 |
UPPER RESPIRATORY TRACT INFECTION |
177 |
0.0038 |
| 564 |
BLOOD MAGNESIUM DECREASED |
33 |
0.0038 |
| 565 |
HYPONATRAEMIA |
215 |
0.0038 |
| 566 |
HAEMOGLOBIN DECREASED |
390 |
0.0038 |
| 567 |
DRUG SCREEN POSITIVE |
30 |
0.0038 |
| 568 |
BONE PAIN |
222 |
0.0038 |
| 569 |
ACUTE CORONARY SYNDROME |
31 |
0.0037 |
| 570 |
PRODUCT COMMUNICATION ISSUE |
33 |
0.0037 |
| 571 |
LIVER FUNCTION TEST INCREASED |
80 |
0.0037 |
| 572 |
HYPERCALCAEMIA |
46 |
0.0037 |
| 573 |
PNEUMOTHORAX |
59 |
0.0037 |
| 574 |
PERICARDIAL EFFUSION |
86 |
0.0037 |
| 575 |
IMMUNE SYSTEM DISORDER |
49 |
0.0037 |
| 576 |
GENERAL PHYSICAL HEALTH DETERIORATION |
427 |
0.0037 |
| 577 |
NIGHTMARE |
127 |
0.0037 |
| 578 |
SUICIDAL IDEATION |
335 |
0.0037 |
| 579 |
VENTRICULAR EXTRASYSTOLES |
38 |
0.0037 |
| 580 |
TRICUSPID VALVE INCOMPETENCE |
29 |
0.0036 |
| 581 |
TENDERNESS |
38 |
0.0036 |
| 582 |
ACUTE RESPIRATORY FAILURE |
70 |
0.0036 |
| 583 |
PAIN |
2230 |
0.0036 |
| 584 |
PHARYNGITIS |
45 |
0.0036 |
| 585 |
NO THERAPEUTIC RESPONSE |
44 |
0.0036 |
| 586 |
MUCOSAL INFLAMMATION |
94 |
0.0036 |
| 587 |
PARKINSONISM |
35 |
0.0036 |
| 588 |
ELECTROCARDIOGRAM QT PROLONGED |
129 |
0.0036 |
| 589 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
92 |
0.0036 |
| 590 |
BONE DISORDER |
65 |
0.0036 |
| 591 |
HAEMATURIA |
122 |
0.0036 |
| 592 |
BLOOD SODIUM DECREASED |
67 |
0.0036 |
| 593 |
CANDIDA INFECTION |
60 |
0.0035 |
| 594 |
ERECTILE DYSFUNCTION |
91 |
0.0035 |
| 595 |
CYTOKINE RELEASE SYNDROME |
71 |
0.0035 |
| 596 |
UVEITIS |
48 |
0.0035 |
| 597 |
ELECTROLYTE IMBALANCE |
41 |
0.0035 |
| 598 |
ABNORMAL DREAMS |
97 |
0.0035 |
| 599 |
BACTERIAL INFECTION |
65 |
0.0035 |
| 600 |
PLEURAL EFFUSION |
211 |
0.0035 |
| 601 |
METASTASES TO LUNG |
40 |
0.0035 |
| 602 |
HYPERTENSION |
729 |
0.0034 |
| 603 |
ABDOMINAL DISTENSION |
359 |
0.0034 |
| 604 |
APPENDICITIS |
32 |
0.0034 |
| 605 |
DYSPHAGIA |
323 |
0.0034 |
| 606 |
FACIAL PARALYSIS |
29 |
0.0034 |
| 607 |
GOUT |
61 |
0.0034 |
| 608 |
CONDITION AGGRAVATED |
1027 |
0.0034 |
| 609 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
176 |
0.0034 |
| 610 |
TOOTH FRACTURE |
37 |
0.0034 |
| 611 |
WHITE BLOOD CELL COUNT DECREASED |
362 |
0.0033 |
| 612 |
GASTROINTESTINAL DISORDER |
299 |
0.0033 |
| 613 |
ULCER |
53 |
0.0033 |
| 614 |
URINE OUTPUT DECREASED |
29 |
0.0033 |
| 615 |
SQUAMOUS CELL CARCINOMA |
31 |
0.0033 |
| 616 |
BLOOD CALCIUM DECREASED |
37 |
0.0033 |
| 617 |
OEDEMA PERIPHERAL |
400 |
0.0033 |
| 618 |
HAEMATOCRIT DECREASED |
65 |
0.0033 |
| 619 |
MOBILITY DECREASED |
235 |
0.0033 |
| 620 |
GYNAECOMASTIA |
101 |
0.0033 |
| 621 |
MENTAL STATUS CHANGES |
90 |
0.0032 |
| 622 |
HYPOXIA |
114 |
0.0032 |
| 623 |
PARALYSIS |
46 |
0.0032 |
| 624 |
SUBDURAL HAEMATOMA |
46 |
0.0032 |
| 625 |
LUNG NEOPLASM MALIGNANT |
132 |
0.0032 |
| 626 |
DIARRHOEA HAEMORRHAGIC |
30 |
0.0032 |
| 627 |
MENTAL DISORDER |
139 |
0.0032 |
| 628 |
VOMITING |
1500 |
0.0032 |
| 629 |
REBOUND EFFECT |
36 |
0.0032 |
| 630 |
GASTRIC ULCER |
60 |
0.0032 |
| 631 |
VIRAL INFECTION |
105 |
0.0032 |
| 632 |
ABDOMINAL PAIN |
734 |
0.0032 |
| 633 |
CORONARY ARTERY DISEASE |
95 |
0.0031 |
| 634 |
C-REACTIVE PROTEIN INCREASED |
114 |
0.0031 |
| 635 |
DRUG INTOLERANCE |
302 |
0.0031 |
| 636 |
OESOPHAGITIS |
34 |
0.0031 |
| 637 |
CYTOPENIA |
38 |
0.0031 |
| 638 |
SPINAL PAIN |
36 |
0.0031 |
| 639 |
LOWER LIMB FRACTURE |
59 |
0.0031 |
| 640 |
PRODUCT USE ISSUE |
574 |
0.0031 |
| 641 |
FLUID RETENTION |
155 |
0.0030 |
| 642 |
MOTOR DYSFUNCTION |
31 |
0.0030 |
| 643 |
CONVULSION |
173 |
0.0030 |
| 644 |
GASTROOESOPHAGEAL REFLUX DISEASE |
243 |
0.0030 |
| 645 |
ASTHENIA |
1135 |
0.0030 |
| 646 |
AFFECT LABILITY |
29 |
0.0030 |
| 647 |
BLOOD CHOLESTEROL INCREASED |
140 |
0.0030 |
| 648 |
PNEUMONIA |
970 |
0.0030 |
| 649 |
PRODUCT USE COMPLAINT |
47 |
0.0030 |
| 650 |
STAPHYLOCOCCAL INFECTION |
98 |
0.0030 |
| 651 |
ANGINA PECTORIS |
85 |
0.0030 |
| 652 |
SHOCK |
68 |
0.0030 |
| 653 |
OEDEMA |
160 |
0.0029 |
| 654 |
HYPOMAGNESAEMIA |
41 |
0.0029 |
| 655 |
BODY TEMPERATURE INCREASED |
60 |
0.0029 |
| 656 |
DELIRIUM |
102 |
0.0029 |
| 657 |
HELICOBACTER INFECTION |
30 |
0.0029 |
| 658 |
TYPE 2 DIABETES MELLITUS |
98 |
0.0029 |
| 659 |
DEAFNESS |
76 |
0.0029 |
| 660 |
RASH PAPULAR |
65 |
0.0029 |
| 661 |
HERPES ZOSTER |
166 |
0.0029 |
| 662 |
DYSURIA |
106 |
0.0029 |
| 663 |
NERVE INJURY |
32 |
0.0029 |
| 664 |
THERAPY NON-RESPONDER |
129 |
0.0029 |
| 665 |
DYSPNOEA EXERTIONAL |
108 |
0.0029 |
| 666 |
GAIT DISTURBANCE |
548 |
0.0029 |
| 667 |
INCONTINENCE |
30 |
0.0028 |
| 668 |
WEIGHT DECREASED |
791 |
0.0028 |
| 669 |
NEUTROPHIL COUNT INCREASED |
29 |
0.0028 |
| 670 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
112 |
0.0028 |
| 671 |
VISUAL ACUITY REDUCED |
94 |
0.0028 |
| 672 |
POLLAKIURIA |
118 |
0.0028 |
| 673 |
MYALGIA |
479 |
0.0028 |
| 674 |
MOUTH ULCERATION |
59 |
0.0028 |
| 675 |
MASS |
39 |
0.0028 |
| 676 |
VENTRICULAR TACHYCARDIA |
46 |
0.0028 |
| 677 |
LUNG INFECTION |
43 |
0.0028 |
| 678 |
INTERSTITIAL LUNG DISEASE |
134 |
0.0028 |
| 679 |
ACUTE MYELOID LEUKAEMIA |
43 |
0.0028 |
| 680 |
PRODUCT DOSE OMISSION |
180 |
0.0028 |
| 681 |
SKIN ULCER |
71 |
0.0027 |
| 682 |
CEREBRAL INFARCTION |
67 |
0.0027 |
| 683 |
INTENTIONAL PRODUCT USE ISSUE |
240 |
0.0027 |
| 684 |
CYANOSIS |
43 |
0.0027 |
| 685 |
GENERALISED TONIC-CLONIC SEIZURE |
45 |
0.0027 |
| 686 |
OSTEOARTHRITIS |
115 |
0.0027 |
| 687 |
UPPER LIMB FRACTURE |
54 |
0.0027 |
| 688 |
BLOOD POTASSIUM INCREASED |
44 |
0.0027 |
| 689 |
DEPRESSED MOOD |
143 |
0.0027 |
| 690 |
CARDIAC FAILURE |
217 |
0.0027 |
| 691 |
MYELOSUPPRESSION |
97 |
0.0027 |
| 692 |
PULMONARY MASS |
40 |
0.0027 |
| 693 |
HIP ARTHROPLASTY |
41 |
0.0027 |
| 694 |
TACHYCARDIA |
237 |
0.0027 |
| 695 |
DYSARTHRIA |
100 |
0.0027 |
| 696 |
NOCTURIA |
32 |
0.0026 |
| 697 |
MELAENA |
58 |
0.0026 |
| 698 |
INFLAMMATION |
136 |
0.0026 |
| 699 |
LUNG DISORDER |
129 |
0.0026 |
| 700 |
VENTRICULAR FIBRILLATION |
29 |
0.0026 |
| 701 |
LABORATORY TEST ABNORMAL |
77 |
0.0026 |
| 702 |
SLEEP DISORDER |
183 |
0.0026 |
| 703 |
TENDONITIS |
40 |
0.0026 |
| 704 |
HALLUCINATION, AUDITORY |
41 |
0.0026 |
| 705 |
NIGHT SWEATS |
83 |
0.0026 |
| 706 |
CEREBRAL HAEMORRHAGE |
92 |
0.0026 |
| 707 |
LETHARGY |
147 |
0.0026 |
| 708 |
DISORIENTATION |
101 |
0.0025 |
| 709 |
LEUKOCYTOSIS |
46 |
0.0025 |
| 710 |
DECREASED APPETITE |
587 |
0.0025 |
| 711 |
NEOPLASM |
29 |
0.0025 |
| 712 |
EPILEPSY |
77 |
0.0025 |
| 713 |
HYPOTHYROIDISM |
80 |
0.0025 |
| 714 |
RASH |
1091 |
0.0025 |
| 715 |
ILEUS |
31 |
0.0025 |
| 716 |
ALTERED STATE OF CONSCIOUSNESS |
54 |
0.0025 |
| 717 |
HYPOKINESIA |
36 |
0.0025 |
| 718 |
NEURALGIA |
60 |
0.0025 |
| 719 |
BLOOD PRESSURE SYSTOLIC INCREASED |
48 |
0.0025 |
| 720 |
INSOMNIA |
651 |
0.0024 |
| 721 |
COORDINATION ABNORMAL |
34 |
0.0024 |
| 722 |
DIARRHOEA |
1571 |
0.0024 |
| 723 |
INTERVERTEBRAL DISC PROTRUSION |
53 |
0.0024 |
| 724 |
FEAR |
65 |
0.0024 |
| 725 |
RED BLOOD CELL COUNT DECREASED |
69 |
0.0024 |
| 726 |
CORONARY ARTERY OCCLUSION |
33 |
0.0024 |
| 727 |
MUSCULOSKELETAL CHEST PAIN |
37 |
0.0024 |
| 728 |
NAUSEA |
1890 |
0.0024 |
| 729 |
BLINDNESS |
97 |
0.0024 |
| 730 |
RESPIRATORY TRACT INFECTION |
62 |
0.0024 |
| 731 |
HYPERSENSITIVITY |
441 |
0.0024 |
| 732 |
BACK PAIN |
551 |
0.0024 |
| 733 |
HAEMOPTYSIS |
66 |
0.0024 |
| 734 |
CHILLS |
277 |
0.0024 |
| 735 |
CIRCULATORY COLLAPSE |
40 |
0.0023 |
| 736 |
WHEEZING |
139 |
0.0023 |
| 737 |
APATHY |
34 |
0.0023 |
| 738 |
COMA |
111 |
0.0023 |
| 739 |
MUSCULAR WEAKNESS |
263 |
0.0023 |
| 740 |
HYPOPHAGIA |
59 |
0.0023 |
| 741 |
FEMUR FRACTURE |
71 |
0.0023 |
| 742 |
HOSPITALISATION |
352 |
0.0023 |
| 743 |
PNEUMONITIS |
62 |
0.0023 |
| 744 |
GASTROINTESTINAL HAEMORRHAGE |
190 |
0.0023 |
| 745 |
PERITONITIS |
47 |
0.0023 |
| 746 |
EATING DISORDER |
48 |
0.0023 |
| 747 |
APHASIA |
68 |
0.0022 |
| 748 |
HEPATIC CANCER |
54 |
0.0022 |
| 749 |
HYPERHIDROSIS |
289 |
0.0022 |
| 750 |
INFUSION RELATED REACTION |
148 |
0.0022 |
| 751 |
NODULE |
29 |
0.0022 |
| 752 |
INFECTION |
321 |
0.0022 |
| 753 |
DEHYDRATION |
294 |
0.0022 |
| 754 |
PERICARDITIS |
37 |
0.0022 |
| 755 |
RESTLESSNESS |
80 |
0.0022 |
| 756 |
HIP FRACTURE |
70 |
0.0022 |
| 757 |
BLOOD POTASSIUM DECREASED |
65 |
0.0022 |
| 758 |
DERMATITIS |
45 |
0.0021 |
| 759 |
INTENTIONAL PRODUCT MISUSE |
188 |
0.0021 |
| 760 |
PULMONARY ARTERIAL HYPERTENSION |
31 |
0.0021 |
| 761 |
COLITIS |
81 |
0.0021 |
| 762 |
OBESITY |
34 |
0.0021 |
| 763 |
RASH PRURITIC |
115 |
0.0021 |
| 764 |
MOVEMENT DISORDER |
68 |
0.0021 |
| 765 |
DISTURBANCE IN ATTENTION |
114 |
0.0021 |
| 766 |
ILL-DEFINED DISORDER |
128 |
0.0021 |
| 767 |
RESPIRATORY DISORDER |
63 |
0.0021 |
| 768 |
INTERNATIONAL NORMALISED RATIO INCREASED |
60 |
0.0021 |
| 769 |
MUSCULOSKELETAL DISORDER |
40 |
0.0021 |
| 770 |
PULMONARY OEDEMA |
94 |
0.0021 |
| 771 |
TOXICITY TO VARIOUS AGENTS |
353 |
0.0021 |
| 772 |
DEEP VEIN THROMBOSIS |
136 |
0.0021 |
| 773 |
ISCHAEMIC STROKE |
37 |
0.0021 |
| 774 |
SKIN DISORDER |
69 |
0.0021 |
| 775 |
CONFUSIONAL STATE |
333 |
0.0021 |
| 776 |
ADVERSE DRUG REACTION |
185 |
0.0021 |
| 777 |
PNEUMONIA ASPIRATION |
51 |
0.0020 |
| 778 |
PERIPHERAL COLDNESS |
28 |
0.0020 |
| 779 |
DIABETES MELLITUS INADEQUATE CONTROL |
36 |
0.0020 |
| 780 |
PHOTOPHOBIA |
38 |
0.0020 |
| 781 |
MYOCARDIAL INFARCTION |
351 |
0.0020 |
| 782 |
HYPOAESTHESIA |
301 |
0.0020 |
| 783 |
PALPITATIONS |
235 |
0.0020 |
| 784 |
FATIGUE |
1561 |
0.0020 |
| 785 |
COGNITIVE DISORDER |
93 |
0.0020 |
| 786 |
DISEASE PROGRESSION |
235 |
0.0020 |
| 787 |
VERTIGO |
120 |
0.0020 |
| 788 |
PULMONARY EMBOLISM |
187 |
0.0020 |
| 789 |
COUGH |
547 |
0.0019 |
| 790 |
WEIGHT INCREASED |
436 |
0.0019 |
| 791 |
SUICIDE ATTEMPT |
118 |
0.0019 |
| 792 |
MANIA |
32 |
0.0019 |
| 793 |
HAEMORRHAGE INTRACRANIAL |
29 |
0.0019 |
| 794 |
BLINDNESS UNILATERAL |
27 |
0.0019 |
| 795 |
ABASIA |
47 |
0.0019 |
| 796 |
ARRHYTHMIA |
90 |
0.0019 |
| 797 |
SEROTONIN SYNDROME |
36 |
0.0019 |
| 798 |
HYPOTENSION |
374 |
0.0019 |
| 799 |
RASH MACULAR |
65 |
0.0019 |
| 800 |
WHITE BLOOD CELL COUNT INCREASED |
71 |
0.0018 |
| 801 |
CHEST PAIN |
342 |
0.0018 |
| 802 |
PLASMA CELL MYELOMA |
72 |
0.0018 |
| 803 |
PRODUCTIVE COUGH |
88 |
0.0018 |
| 804 |
HYPOGLYCAEMIA |
89 |
0.0018 |
| 805 |
HEADACHE |
1148 |
0.0018 |
| 806 |
SWELLING FACE |
119 |
0.0018 |
| 807 |
AMENORRHOEA |
32 |
0.0018 |
| 808 |
FEEDING DISORDER |
37 |
0.0018 |
| 809 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
327 |
0.0018 |
| 810 |
PRODUCT DISPENSING ERROR |
39 |
0.0018 |
| 811 |
DIABETIC KETOACIDOSIS |
43 |
0.0018 |
| 812 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
45 |
0.0018 |
| 813 |
MALAISE |
777 |
0.0018 |
| 814 |
PHOTOSENSITIVITY REACTION |
29 |
0.0018 |
| 815 |
NEOPLASM PROGRESSION |
61 |
0.0018 |
| 816 |
FAECES DISCOLOURED |
38 |
0.0018 |
| 817 |
CELLULITIS |
88 |
0.0017 |
| 818 |
IRRITABILITY |
105 |
0.0017 |
| 819 |
HAEMORRHOIDS |
34 |
0.0017 |
| 820 |
BLOOD URINE PRESENT |
33 |
0.0017 |
| 821 |
MOOD ALTERED |
47 |
0.0017 |
| 822 |
POOR QUALITY SLEEP |
37 |
0.0017 |
| 823 |
ANGIOEDEMA |
76 |
0.0017 |
| 824 |
HALLUCINATION |
129 |
0.0017 |
| 825 |
CARDIAC ARREST |
141 |
0.0017 |
| 826 |
BRADYCARDIA |
90 |
0.0017 |
| 827 |
ABNORMAL BEHAVIOUR |
67 |
0.0017 |
| 828 |
PRODUCT USE IN UNAPPROVED INDICATION |
415 |
0.0017 |
| 829 |
SYNOVITIS |
30 |
0.0017 |
| 830 |
AGITATION |
122 |
0.0017 |
| 831 |
HALLUCINATION, VISUAL |
35 |
0.0017 |
| 832 |
URINARY INCONTINENCE |
49 |
0.0017 |
| 833 |
PANIC ATTACK |
60 |
0.0016 |
| 834 |
GAIT INABILITY |
55 |
0.0016 |
| 835 |
METRORRHAGIA |
28 |
0.0016 |
| 836 |
ABDOMINAL PAIN UPPER |
338 |
0.0016 |
| 837 |
ARTHRALGIA |
682 |
0.0016 |
| 838 |
ACCIDENTAL OVERDOSE |
60 |
0.0016 |
| 839 |
OFF LABEL USE |
1436 |
0.0016 |
| 840 |
AGGRESSION |
82 |
0.0016 |
| 841 |
PRURITUS GENERALISED |
35 |
0.0016 |
| 842 |
CARDIOVASCULAR DISORDER |
41 |
0.0016 |
| 843 |
EYE DISORDER |
53 |
0.0016 |
| 844 |
ASTHMA |
180 |
0.0016 |
| 845 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
37 |
0.0016 |
| 846 |
SPEECH DISORDER |
83 |
0.0016 |
| 847 |
AMNESIA |
103 |
0.0016 |
| 848 |
PAIN IN EXTREMITY |
465 |
0.0016 |
| 849 |
SKIN DISCOLOURATION |
72 |
0.0016 |
| 850 |
DEATH |
1342 |
0.0016 |
| 851 |
JOINT SWELLING |
188 |
0.0016 |
| 852 |
STOMATITIS |
94 |
0.0015 |
| 853 |
SOMNOLENCE |
312 |
0.0015 |
| 854 |
INTESTINAL OBSTRUCTION |
58 |
0.0015 |
| 855 |
CONSTIPATION |
334 |
0.0015 |
| 856 |
DISCOMFORT |
93 |
0.0015 |
| 857 |
DYSPNOEA |
858 |
0.0015 |
| 858 |
DIZZINESS |
755 |
0.0015 |
| 859 |
LOSS OF CONSCIOUSNESS |
193 |
0.0015 |
| 860 |
ABDOMINAL PAIN LOWER |
38 |
0.0015 |
| 861 |
RETCHING |
32 |
0.0015 |
| 862 |
URINARY TRACT INFECTION |
255 |
0.0015 |
| 863 |
EXTRA DOSE ADMINISTERED |
60 |
0.0015 |
| 864 |
ATRIAL FIBRILLATION |
144 |
0.0015 |
| 865 |
SKIN EXFOLIATION |
124 |
0.0015 |
| 866 |
FLATULENCE |
83 |
0.0015 |
| 867 |
PARAESTHESIA |
229 |
0.0015 |
| 868 |
ADVERSE EVENT |
134 |
0.0015 |
| 869 |
GLAUCOMA |
28 |
0.0015 |
| 870 |
MUSCULOSKELETAL PAIN |
76 |
0.0014 |
| 871 |
THERAPY CESSATION |
73 |
0.0014 |
| 872 |
HAEMORRHAGE |
148 |
0.0014 |
| 873 |
NEOPLASM MALIGNANT |
94 |
0.0014 |
| 874 |
CHEST DISCOMFORT |
144 |
0.0014 |
| 875 |
MENTAL IMPAIRMENT |
34 |
0.0014 |
| 876 |
ERYTHEMA |
288 |
0.0014 |
| 877 |
COVID-19 |
245 |
0.0014 |
| 878 |
CARDIAC FAILURE CONGESTIVE |
111 |
0.0014 |
| 879 |
DRUG INEFFECTIVE |
1816 |
0.0014 |
| 880 |
OVERDOSE |
296 |
0.0014 |
| 881 |
TINNITUS |
63 |
0.0014 |
| 882 |
THERAPEUTIC RESPONSE DECREASED |
83 |
0.0014 |
| 883 |
SEIZURE |
158 |
0.0014 |
| 884 |
ROAD TRAFFIC ACCIDENT |
57 |
0.0014 |
| 885 |
HAEMATOCHEZIA |
75 |
0.0014 |
| 886 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
96 |
0.0013 |
| 887 |
URINARY RETENTION |
45 |
0.0013 |
| 888 |
DYSPEPSIA |
131 |
0.0013 |
| 889 |
ABDOMINAL DISCOMFORT |
223 |
0.0013 |
| 890 |
EPISTAXIS |
99 |
0.0013 |
| 891 |
LOWER RESPIRATORY TRACT INFECTION |
60 |
0.0013 |
| 892 |
HAEMATOMA |
34 |
0.0013 |
| 893 |
BLISTER |
73 |
0.0013 |
| 894 |
BRONCHITIS |
96 |
0.0013 |
| 895 |
BLOOD PRESSURE DECREASED |
86 |
0.0013 |
| 896 |
SYNCOPE |
128 |
0.0013 |
| 897 |
UNRESPONSIVE TO STIMULI |
33 |
0.0013 |
| 898 |
MUSCULOSKELETAL STIFFNESS |
112 |
0.0013 |
| 899 |
RHEUMATOID ARTHRITIS |
145 |
0.0013 |
| 900 |
PRESYNCOPE |
31 |
0.0013 |
| 901 |
CARDIO-RESPIRATORY ARREST |
53 |
0.0013 |
| 902 |
NECK PAIN |
70 |
0.0013 |
| 903 |
PRURITUS |
478 |
0.0012 |
| 904 |
RECTAL HAEMORRHAGE |
53 |
0.0012 |
| 905 |
OROPHARYNGEAL PAIN |
114 |
0.0012 |
| 906 |
FUNGAL INFECTION |
41 |
0.0012 |
| 907 |
CRYING |
44 |
0.0012 |
| 908 |
DYSKINESIA |
49 |
0.0012 |
| 909 |
OXYGEN SATURATION DECREASED |
67 |
0.0012 |
| 910 |
TREMOR |
197 |
0.0012 |
| 911 |
ARTHRITIS |
92 |
0.0012 |
| 912 |
GASTRIC DISORDER |
40 |
0.0012 |
| 913 |
PSORIASIS |
151 |
0.0012 |
| 914 |
MEDICATION ERROR |
64 |
0.0012 |
| 915 |
ILLNESS |
118 |
0.0011 |
| 916 |
CEREBROVASCULAR ACCIDENT |
194 |
0.0011 |
| 917 |
MUSCLE SPASMS |
206 |
0.0011 |
| 918 |
VISION BLURRED |
153 |
0.0011 |
| 919 |
FEELING COLD |
31 |
0.0011 |
| 920 |
DEMENTIA |
31 |
0.0011 |
| 921 |
MEMORY IMPAIRMENT |
152 |
0.0011 |
| 922 |
THROMBOSIS |
89 |
0.0011 |
| 923 |
HYPERSOMNIA |
31 |
0.0011 |
| 924 |
HEART RATE INCREASED |
106 |
0.0011 |
| 925 |
TRANSIENT ISCHAEMIC ATTACK |
36 |
0.0011 |
| 926 |
FALL |
349 |
0.0010 |
| 927 |
CARDIAC DISORDER |
98 |
0.0010 |
| 928 |
BALANCE DISORDER |
90 |
0.0010 |
| 929 |
BLOOD PRESSURE INCREASED |
157 |
0.0010 |
| 930 |
EYE SWELLING |
38 |
0.0010 |
| 931 |
URTICARIA |
171 |
0.0010 |
| 932 |
NO ADVERSE EVENT |
183 |
0.0010 |
| 933 |
DRUG ABUSE |
83 |
0.0010 |
| 934 |
INFLUENZA LIKE ILLNESS |
82 |
0.0010 |
| 935 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
54 |
0.0010 |
| 936 |
SWELLING |
92 |
0.0010 |
| 937 |
HEAD INJURY |
31 |
0.0010 |
| 938 |
CATARACT |
58 |
0.0010 |
| 939 |
PRODUCT STORAGE ERROR |
85 |
0.0010 |
| 940 |
RHINORRHOEA |
62 |
0.0010 |
| 941 |
INFLUENZA |
106 |
0.0009 |
| 942 |
HYPOACUSIS |
40 |
0.0009 |
| 943 |
OCULAR HYPERAEMIA |
44 |
0.0009 |
| 944 |
DRUG DOSE OMISSION |
152 |
0.0009 |
| 945 |
ANGER |
31 |
0.0009 |
| 946 |
CONTUSION |
88 |
0.0009 |
| 947 |
ALOPECIA |
179 |
0.0009 |
| 948 |
INJURY |
64 |
0.0009 |
| 949 |
ECZEMA |
47 |
0.0009 |
| 950 |
DRY MOUTH |
72 |
0.0009 |
| 951 |
EYE PAIN |
50 |
0.0009 |
| 952 |
PERIPHERAL SWELLING |
136 |
0.0009 |
| 953 |
MOOD SWINGS |
28 |
0.0009 |
| 954 |
VAGINAL HAEMORRHAGE |
38 |
0.0009 |
| 955 |
SURGERY |
51 |
0.0009 |
| 956 |
THERAPEUTIC RESPONSE UNEXPECTED |
39 |
0.0009 |
| 957 |
MALIGNANT NEOPLASM PROGRESSION |
89 |
0.0009 |
| 958 |
PRODUCT SUBSTITUTION ISSUE |
50 |
0.0009 |
| 959 |
NERVOUSNESS |
45 |
0.0009 |
| 960 |
BLOOD GLUCOSE INCREASED |
162 |
0.0009 |
| 961 |
DYSPHONIA |
50 |
0.0009 |
| 962 |
NASAL CONGESTION |
50 |
0.0008 |
| 963 |
FEELING HOT |
52 |
0.0008 |
| 964 |
DYSGEUSIA |
61 |
0.0008 |
| 965 |
UNEVALUABLE EVENT |
62 |
0.0008 |
| 966 |
BURNING SENSATION |
57 |
0.0008 |
| 967 |
THERAPY INTERRUPTED |
57 |
0.0008 |
| 968 |
INTENTIONAL OVERDOSE |
51 |
0.0008 |
| 969 |
FEELING ABNORMAL |
188 |
0.0008 |
| 970 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
35 |
0.0008 |
| 971 |
INCORRECT DOSE ADMINISTERED |
169 |
0.0007 |
| 972 |
SINUSITIS |
74 |
0.0007 |
| 973 |
ARTHROPATHY |
39 |
0.0007 |
| 974 |
DRY EYE |
35 |
0.0007 |
| 975 |
NASOPHARYNGITIS |
128 |
0.0007 |
| 976 |
MIGRAINE |
64 |
0.0007 |
| 977 |
DRY SKIN |
87 |
0.0007 |
| 978 |
THROAT IRRITATION |
29 |
0.0006 |
| 979 |
VISUAL IMPAIRMENT |
78 |
0.0006 |
| 980 |
COMPLETED SUICIDE |
52 |
0.0006 |
| 981 |
FLUSHING |
62 |
0.0006 |
| 982 |
BLOOD GLUCOSE DECREASED |
28 |
0.0006 |
| 983 |
UNDERDOSE |
40 |
0.0005 |
| 984 |
ANAPHYLACTIC REACTION |
30 |
0.0005 |
| 985 |
ACNE |
41 |
0.0005 |
| 986 |
DRUG EFFECT DECREASED |
28 |
0.0005 |
| 987 |
HOT FLUSH |
38 |
0.0005 |
| 988 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
94 |
0.0005 |
| 989 |
PROSTATE CANCER |
35 |
0.0004 |
| 990 |
INJECTION SITE REACTION |
29 |
0.0004 |
| 991 |
PRODUCT QUALITY ISSUE |
46 |
0.0003 |
| 992 |
INJECTION SITE PAIN |
75 |
0.0002 |